Ligand Pharmaceuticals Incorporated (LGND)
Nasdaq • LGND • US53220K5048
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 13.9% of free float sold short, 10.6 days to cover, cost to borrow 0.49%. Sign up for live short interest data.
Market Cap
6.12b USD | # 2192 in US
Volume
234.27k shares | 69.48m USD
Shares Outstanding
20m
Free Float Shares
97.74% | 19.55m
